The trading price of Novabay Pharmaceuticals Inc (AMEX:NBY) closed higher on Friday, January 17, and closing at $0.73, 4.70% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $0.68 and $0.7399. In examining the 52-week price action we see that the stock hit a 52-week high of $9.08 and a 52-week low of $0.36. Over the past month, the stock has gained 29.09% in value.
Novabay Pharmaceuticals Inc, whose market valuation is $3.58 million at the time of this writing, is expected to release its quarterly earnings report in February. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest NBY has a Hold on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a Hold, while an average of long term indicators suggests that the stock is currently 50% Sell.
Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned NBY a recommendation rating is 1. Out of them, 0 rate it a Hold, while 1 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Novabay Pharmaceuticals Inc (NBY) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.
A quick review shows that NBY’s price is currently 18.44% off the SMA20 and 15.68% off the SMA50. The RSI metric on the 14-day chart is currently showing 63.42, and weekly volatility stands at 9.92%. When measured over the past 30 days, the indicator reaches 9.80%. Novabay Pharmaceuticals Inc (AMEX:NBY)’s beta value is currently sitting at 0.65, while the Average True Range indicator is currently displaying 0.06.
To see how Novabay Pharmaceuticals Inc stock has been performing in comparison to its peers in the industry, here are the numbers: NBY stock’s performance was 4.70% in the latest trading, and -87.06% in the past year.
An evaluation of the daily trading volume of Novabay Pharmaceuticals Inc (AMEX:NBY) indicates that the 3-month average is 559.72K. However, this figure has increased over the past 10 days to an average of 0.73.
Currently, records show that 4.89 million of the company’s shares remain outstanding. The insiders hold 0.01% of outstanding shares, whereas institutions hold 10.32%. The stats also highlight that short interest as of 2024-12-31, stood at 62921.0 shares, resulting in a short ratio of 0.38 at that time. From this, we can conclude that short interest is 129.00 of the company’s total outstanding shares. It is noteworthy that short shares in December were down slightly from the previous month’s figure, which was 73168.0. However, since the stock’s price has seen 21.90% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.
